HPV vaccine becoming more common among college women
Gardasil®, the vaccine that prevents contraction of the sexually transmitted human papillomavirus, or HPV, is becoming more frequent since its approval last June. Health officials encourage all females up to the age of 26 to get the vaccination and college-age women are responding to the suggestion.
Since the vaccine became available, Watkins Health Center has vaccinated 35 women. Despite initial low numbers, Watkins has seen a recent surge in vaccinations and it is expected to continue.
“It’s picking up,” Supervisor of Nursing at Watkins Patty Quinlan, said. “The reason is because insurance is picking it up.”
Insurance companies are slowly adding the vaccine to their programs, making it more affordable, Quinlan said. The vaccine Gardasil® was approved in June by the Food and Drug Administration (FDA). The Center for Disease Control names HPV as the most commonly contracted sexually transmitted disease. Health officials say clinical trials of the vaccine show it to be 100 percent effective in preventing the contraction of four strains of the HPV virus, two of which are known to cause cervical cancer.
Statistics show that 50 percent of sexually active people have HPV, making it more frequent on college campuses than people think, Quinlan said. After a suggestion from both her mother and her physician, sophomore Jordan Krouse decided to get the vaccine.
“I just think it’s a good decision,” she said. “Even if you don’t have sex until you get married, your husband could have HPV and you would still be exposed. It’s just safe to get the shots.”
The HPV virus causes 70 percent of cervical cancer cases, the second leading cancer-killer of women, and can be contracted through sexual intercourse as well as skin-on-skin contact. Statistics show that 80 percent of sexually active women will contract some form of HPV by the time they reach 50.
Krouse said her opinion is different from what she’s heard from other women. Conversations with friends make her think they don’t understand the seriousness of the disease she said. “I think people only think it’s an STD,” Krouse said. “And no one thinks they’re going to get an STD.”
Since the approval of Gardasil®, advertisements and public awareness campaigns have spread the word about HPV and the vaccine.
“I have two daughters in their 20s and I see the advertisements at the stores they shop at and the magazines they get,” Quinlan said. “It’s hard to say that there isn’t enough publicity.”
Women health advocates and political groups are strongly encouraging the routine vaccination of approved age groups, ages 9-26. Ellen Schleicher, a member of Women in Government, a non-profit organization of women state legislators, said that getting the vaccination is a good way to avoid contracting HPV and cut the risk of developing cervical cancer.
“The purpose is to help women with something they face everyday,” Schleicher said. “Cervical cancer is something that can be stopped with regular and required screening.”
The vaccine is administered in three shots over a six-month period and is available at most hospitals and doctor’s offices. A second HPV vaccine, Cervarix, is likely to be approved by next year.